Quest Diagnostics (DGX) Non Operating Income (2009 - 2026)
Quest Diagnostics (DGX) posted Non Operating Income of -$63.0 million for Q2 2026, up 3.08% sequentially from -$65.0 million in Q1 2026, and up 5.97% YoY from -$59.5 million in Q2 2025.
Quest Diagnostics (DGX) Non Operating Income (2009 - 2026) Analysis & Trends
Quest Diagnostics has reported Non Operating Income for 18 years, with the latest figure at -$63.0 million in Q2 2026.
- Quarterly Non Operating Income rose 5.97% year-over-year to -$63.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$258.0 million (down 2.79% YoY) and the FY2025 annual result came in at -$264.0 million, down 31.34% from the prior year.
- Non Operating Income advanced to -$63.0 million in Q2 2026 per DGX's latest filing, from -$65.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at -$26.0 million in Q4 2022 and troughed at -$70.0 million in Q1 2025.
- A 5-year average of -$51.7 million and a median of -$55.0 million in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income tumbled 2150.0% in 2022, then surged 54.1% in 2023.
- Over 5 years, Non Operating Income stood at -$26.0 million in 2022, then tumbled by 53.85% to -$40.0 million in 2023, then slumped by 62.5% to -$65.0 million in 2024, then rose by 1.54% to -$64.0 million in 2025, then climbed by 1.56% to -$63.0 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$63.0 million, -$65.0 million, and -$64.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.86 Bn | 209.80 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.41 Bn | 136.07 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.33 Bn | 46.13 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.71 Bn | 37.90 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.35 Bn | 37.27 Bn | 1.44 Bn | - |
| 6 | Natera | 38.97 Bn | 37.87 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.09 Bn | 28.92 Bn | 770.00 Mn | 15.00 Mn |
| 8 | Mettler Toledo International | 28.70 Bn | 28.65 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.19 Bn | 25.56 Bn | 1.03 Bn | -63.00 Mn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -63.00 Mn |
| Mar 31, 2026 | -65.00 Mn |
| Dec 31, 2025 | -64.00 Mn |
| Sep 30, 2025 | -66.00 Mn |
| Jun 30, 2025 | -67.00 Mn |
| Mar 31, 2025 | -70.00 Mn |
| Dec 31, 2024 | -65.00 Mn |
| Sep 30, 2024 | -49.00 Mn |
| Jun 30, 2024 | -44.00 Mn |
| Mar 31, 2024 | -43.00 Mn |
| Dec 31, 2023 | -40.00 Mn |
| Sep 30, 2023 | -43.00 Mn |
| Jun 30, 2023 | -31.00 Mn |
| Mar 31, 2023 | -28.00 Mn |
| Dec 31, 2022 | -26.00 Mn |
| Sep 30, 2022 | -41.00 Mn |
| Jun 30, 2022 | -65.00 Mn |
| Mar 31, 2022 | -61.00 Mn |
| Dec 31, 2021 | -34.00 Mn |
| Sep 30, 2021 | 2.00 Mn |